在甲状腺癌中缺氧-HIF-1α-环素轴的影响
Ye Yang1, Junyi Wu2, Huiqin Zhu3
1Department of Obstetrics and Gynecology, Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Hongkou, Shanghai 200080, P.R. China.
Oncology reports
|February 23, 2024
概括
这项研究揭示了一种低氧-低氧诱导因素1亚单元α (HIF-1α) - 环素通路,导致侵袭性甲状腺癌 (TC) 的进展. 针对这一轴可能为高级TC提供新的治疗策略.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 甲状腺癌 (TC) 发病率正在上升,具有侵略性的亚型带来临床挑战.
- 在TC进展的基础上的分子机制,特别是在低氧条件下,需要进一步阐明.
研究的目的:
- 为了研究缺氧诱导因子1亚单元α (HIF-1α) - - 静轴在甲状腺癌进展中的作用.
- 通过这个轴来确定缺氧如何影响TC细胞行为和新陈代谢.
主要方法:
- 在95个临床TC组织中分析质素和HIF-1α表达,与正常的甲状腺组织相比.
- 在体外研究评估缺氧对TC细胞活力,入侵和华堡效应的影响,有和没有骨操纵.
- 分子测定包括免疫沉和双化酶记者测定,以确认HIF-1α与质素促进体结合.
主要成果:
- 在TC组织中观察到升调的环素和HIF-1α表达.
- 缺氧增强了TC细胞的活力和入侵,这种效应通过静素下调逆转.
- 在TC中因缺氧诱导的华堡效应被静素沉默减弱.
- 低氧激活了HIF-1α,它通过与其促进体结合,直接调节质素的表达.
结论:
- 在甲状腺癌中确定了缺氧-HIF-1α-环素信号轴.
- 这个轴在TC中促进攻击性特征和代谢重编程方面发挥着至关重要的作用.
- 这些发现表明,对于治疗晚期甲状腺癌的潜在治疗点.
相关概念视频
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Functions of Thyroid Hormones
2.7K
The thyroid hormone (TH) plays a pivotal role in the intricate orchestration of physiological processes, exerting profound effects on development, metabolism, and homeostasis throughout different life stages.
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
TH is indispensable for the normal development and maturation of the skeletal, muscular, and nervous systems during fetal and childhood growth. It facilitates bone mineral turnover and regulates protein synthesis in developing tissues, contributing significantly to overall growth and...
2.7K
Adaptive Mechanisms in Cancer Cells
5.8K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Synthesis and Regulation of Thyroid Hormones
4.6K
Low blood levels of the thyroid hormones — triiodothyronine (T3) and thyroxine (T4) — signal the hypothalamus to release the thyrotropin-releasing hormone (TRH). TRH then reaches the pituitary gland and stimulates the release of thyroid-stimulating hormone(TSH) into the bloodstream.
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
Upon reaching the thyroid gland, TSH stimulates the follicular cells' active uptake of iodide ions from the blood. The ions diffuse to the apical surface of the cells and are oxidized to iodine. The...
4.6K
PI3K/mTOR/AKT Signaling Pathway
3.6K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.6K


